## Abstract ## Background The aim of the present study was to analyse the expression of adhesion molecules in childhood nonโHodgkin lymphomas and to correlate the findings with clinical features and prognosis. ## Procedure Samples were obtained from pleural and peritoneal fluids, bone marrow asp
Expression of leukocyte adhesion molecules (ICAM-1/LFA-1) related to clinical behaviour in B cell lymphomas
โ Scribed by Yoshihiro Nozawa; Yoshiko Yamaguchi; Kunihiko Tominaga; Hiroshi Hojo; Masafumi Abe; Haruki Wakasa
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Volume
- 10
- Category
- Article
- ISSN
- 0278-0232
No coin nor oath required. For personal study only.
โฆ Synopsis
We investigated the expression of adhesion molecules of lymphocyte function-associated antigen-lu(LFAlu) and its ligand intercellular adhesion molecule-1 (ICAM-1) on 74 well-characterized B cell lymphomas.
The LFA-1 was expressed on B cell lymphomas (2 1/74; 28 per cent), but to a lesser degree than ICAM-1 which was highly expressed (48/74 cases; 64 per cent).
From the results of bone marrow examination of 39 cases with B cell lymphomas, 13 of 16 cases with a lack of ICAM-I molecule showed a higher incidence of marrow involvement, but nine of 23 cases with the expression of ICAM-1 molecule showed a lower incidence.
These findings suggest that the lack of expression of the ICAM-I molecule by B cell lymphomas correlates with bone marrow involvement by lymphoma cells ($ ~0 . 0 5 ) .
Expression of the LFA-1 molecule appears not to correlate with marrow involvement (p < 0.05).
KEY WORDS Adhesion molecule Bone marrow B cell lymphoma Lymphocyte function-associated antigen-1 (LFA-1) Intercellular adhesion molecule-1 (ICAM-1)
๐ SIMILAR VOLUMES
The peritumoural inflammatory infiltrate in basal cell carcinoma (BCC) of the skin consists mainly of T lymphocytes which hardly invade the tumour nests. The absence of intercellular adhesion molecule-1 (ICAM-1) on BCC cells may explain the lack of tumour-infiltrating cells and the lack of an active
## Abstract Cyclin B1, identified as a regulator of late cell cycle, is involved in the development and progression of a variety of human malignancies. To clarify the role of cyclin B1 in the pathogenesis and prognosis of renal cell carcinoma (RCC), protein expression was compared with clinicopatho